Neutral impactCompany
Epigral Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018
NSE 1 hr ago·15 Oct 2026, 12:56 pm
EpigralEpigral Limited has submitted a certificate to the stock exchanges to comply with SEBI’s Deposition Regulations for the quarter ending September 30, 2026. This document confirms that the company has maintained the required number of depository participants and adhered to regulatory standards during this period.
This disclosure is a routine corporate governance requirement and does not indicate any operational changes. For investors, it serves as a confirmation that the company is following proper compliance procedures, which helps maintain transparency and trust in its financial reporting.
Investors should monitor future announcements for any updates on the company's financial performance or other regulatory filings. This filing is part of the standard regulatory cycle and does not carry immediate market-moving implications.
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Epigral (EPIGRAL).
- Category: Company.
Why it matters
A routine update for Epigral. Use the price and stock snapshot to gauge how the market is responding.
